J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falk, J.
Right arrow Articles by Weil, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falk, J.
Right arrow Articles by Weil, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Effects of hetastarch and albumin on coagulation in patients with septic shock

JL Falk, EC Rackow, ME Astiz, and MH Weil

The effect of 6% hydroxyethyl starch (hetastarch) and 5% human serum albumin (albumin) infusion on coagulation in 12 patients with septic shock was evaluated. Patients were randomly assigned to receive either albumin (N = 6) or hetastarch (N = 6) infusion over a 24-hour study interval. The prothrombin time (PT), partial thromboplastin time (PTT), and quantitative platelet count (PC) were obtained prior to and following 24 hours of fluid infusion. Hetastarch patients received 4934 +/- 1354 mL and albumin patients received 3067 +/- 256 mL over the study interval. After hetastarch infusion, the PT increased 2.2 +/- 0.7 seconds, PTT increased 20.0 +/- 4.1 seconds (P less than .01), and PC decreased 158 +/- 36 X 10(3)/mm3 (P less than .02). After albumin administration, the PT decreased 1.2 +/- 1.7 seconds, PTT increased 20.5 +/- 10.6 seconds and PC decreased 100 +/- 34 X 10(3)/mm3. There were no significant differences in the changes in PT, PTT, or PC between the groups. The authors conclude that hetastarch infusion does not result in increased bleeding in patients with septic shock compared with albumin infusion, despite moderate effects on the hemostatic coagulation profile.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
M. Jacob, D. Chappell, F. Bilotta, G. Rosa, J. A. Myburgh, D. J. Cooper, S. Finfer, and the SAFE Study Investigators
Saline or Albumin for Fluid Resuscitation in Traumatic Brain Injury
N. Engl. J. Med., December 20, 2007; 357(25): 2634 - 2636.
[Full Text] [PDF]

Home page
 Arch SurgHome page
M. E. Barron, M. M. Wilkes, and R. J. Navickis
A Systematic Review of the Comparative Safety of Colloids
Arch Surg, May 1, 2004; 139(5): 552 - 563.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. Boldt
The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units?
Anesth. Analg., October 1, 2000; 91(4): 887 - 895.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
M. Offringa
Excess mortality after human albumin administration in critically ill patients
BMJ, July 25, 1998; 317(7153): 223 - 224.
[Full Text]

Home page
 CLIN APPL THROMB HEMOSTHome page
R. L. Bick
Evaluation of a New Hydroxyethyl Starch, Preparation (HextendTM) on Selected Coagulation Parameters
Clinical and Applied Thrombosis/Hemostasis, June 1, 1995; 1(3): 215 - 229.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Clinical Pharmacology